Physician profile
Robert E Klenck
NPI 1154411858
$2,705.31
in general payments reported to CMS, 2019-2025
11 companies · $42.90 in 2025
The $42.90 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $557 · 2020: $156 · 2021: $23.34 · 2022: $966 · 2023: $65.74 · 2024: $894 · 2025: $42.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $567 · Food and Beverage: $436.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $567.46 |
| Food and Beverage | $435.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $847.88 | 2024-2025 | Rosa, Persona, Synovasure Alpha Defensin |
| Medacta USA, INC. | $789.10 | 2022 | |
| Stryker Corporation | $445.43 | 2019-2022 | |
| Heron Therapeutics, INC. | $155.16 | 2023-2024 | Zynrelef |
| Smith+Nephew, INC. | $154.82 | 2020-2022 | |
| Medtronic USA, INC. | $141.72 | 2019 | |
| Depuy Synthes Sales INC. | $93.12 | 2019-2022 | |
| Davol INC. | $21.25 | 2019 | |
| Intellijoint Surgical INC. | $21.22 | 2020 | |
| Integra Lifesciences Corporation | $18.03 | 2022 | |
| Pfizer INC. | $17.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Klenck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.